Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksALKEM
resources
ALKEM

Alkem Laboratories Ltd.

NSE: ALKEM
BSE: 539523
Sector: Healthcare
Industry: Pharmaceuticals
4,947.00-66.5 (-1.33%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Alkem Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Alkem Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General21 Oct 2026
    Announcement Under Regulation 30 (LODR)- Intimation Regarding Initiation Of Forensic Audit
    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III thereto, we wish to inform you that ....
  2. Change in Management12 Oct 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Please find attached herewith intimation for appointment of Mr. Laxmikant Tiwari and Mr. Nilesh Vartak as Senior Management Personnels of the Company.
  3. Cessation24 Sept 2026
    Announcement under Regulation 30 (LODR)-Cessation
    Please find attached herewith intimation for change in Key Managerial Personnel - Resignation of Chief Financial Officer
  4. Analyst / Investor Meet23 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find attached herewith intimation of Schedule of Analyst / Institutional Investor Meeting.
  5. Closure of Trading Window22 Sept 2026
    Closure of Trading Window
    Please find attached herewith intimation for closure of trading window.
  6. General21 Sept 2026
    Disclosure Under Regulation 30 Of SEBI (LODR) Regulations
    Please find attached herewith intimation for issue of corporate guarantee by the Company.
  7. Press Release / Media Release16 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial - onset seizures in adult patients.
  8. Change in Management15 Sept 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Please find attached herewith intimation for appointment of Dr. Shubhadeep Sinha as Senior Management Personnel of the Company.
  9. Press Release / Media Release8 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Alkem Laboratories Limited launches Renocia ExoTM, India''s first patented Ginsenoside Exosome - based hair growth serum
  10. AGM27 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find attached herewith Scrutinizer Report for 52nd Annual General Meeting of the Company.
  11. AGM27 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Please find attached herewith Outcome of the 52nd Annual General Meeting of the Company and disclosure of voting results thereat.
  12. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201126 Aug 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund
  13. Court Convened Meeting17 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
    Please find attached herewith Proceedings of the meeting of the equity shareholders of the Company and Scrutinizer''s Report on e-voting.
  14. Newspaper Publication15 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached herewith intimation for a copy of newspaper publication
  15. Analyst / Investor Meet14 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q1FY27 Earnings Conference Call'' is available ....
  16. Closure of Trading Window14 Aug 2026
    Closure of Trading Window
    The Financials Results of the Company for the quarter ended 30th June, 2026 having been communicated to the Stock Exchanges today ie 14th Aug the trading window shall open on 17th Aug, 2026.
  17. General14 Aug 2026
    Announcement Under Reg 30 (LODR)
    Pl find attached herewith intimation under Reg 30
  18. Outcome of Board Meeting14 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Dated 14/08/2026
    Please find enclosed herewith the outcome of Board meeting dated 14th Aug, 2026. The meeting of the Board of Directors of the Company commenced at 11 am and concluded at 13.40 pm. Kindly take the same
  19. General6 Aug 2026
    Update On US FDA Inspection At Company'S Manufacturing Facility Located At Amaliya, Daman
    Please find attached herewith intimation about update on US FDA inspection at Company''s Manufacturing Facility Located at Amaliya, Daman.
  20. Change in Management3 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Please find attached herewith regarding Appointment of Senior Management Personnel.

Frequently Asked Questions

Where can I download the annual report of Alkem Laboratories Ltd.?
Annual reports of Alkem Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Alkem Laboratories Ltd.?
Quarterly earnings results and presentations of Alkem Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Alkem Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Alkem Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Alkem Laboratories Ltd.?
Investor presentations and annual day presentations of Alkem Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Alkem Laboratories Ltd.?
Corporate announcements and regulatory filings of Alkem Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Alkem Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alkem Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Alkem Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Alkem Laboratories Ltd. is INE540L01014. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Alkem Laboratories Ltd. listed?
Alkem Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is ALKEM and the BSE code is -.
Where can I find the shareholding pattern of Alkem Laboratories Ltd.?
The quarterly shareholding pattern of Alkem Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Alkem Laboratories Ltd. on Sharpely?
Share price data for Alkem Laboratories Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.